Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Free Anaesthesia in Elderly Patients Undergoing CABG
NCT07360327Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of dexmedetomidine and ketamine in coronary artery disease (CAD) (2 arms), sponsored by Ain Shams University. Primary endpoints: Enhanced recovery time at 24 hours and Enhanced recovery defined as time of extubation at 24 hours. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
dexmedetomidineketamine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT07360327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07360327.